Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.58 -0.17 (-5.74%)
As of: Nov 10, 2026 · 11:40 AM EST

Galmed Pharmaceuticals (EOCN) Convertible Debt (2022 - 2025)

Updated

Galmed Pharmaceuticals' Convertible Debt came in at $3.73 million for Q4 2025, down 3.1% from $3.85 million a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Convertible Debt (2022 - 2025) Analysis & Trends

Going back to Q4 2022, Galmed Pharmaceuticals' Convertible Debt data covers 4 quarters.

  • Convertible Debt carries a three-year compound annual growth rate of -3.0% (FY2022 to FY2025).
  • Going back by year, Convertible Debt was $3.85 million in FY2024 and $4.09 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Galmed Pharmaceuticals 1.40 Mn -43.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.73 Mn
Dec 31, 2024 3.85 Mn
Mar 31, 2023 4.45 Mn
Dec 31, 2022 4.09 Mn
API Access

Galmed Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=EOCN&period=max&api_key=YOUR_API_KEY